Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SOBI.STthis companySwedish Orphan Biovitrum AB	SEK 496.60	239.42×	3.04×	4.06×	11.41×	164.7%	43.6%	28.5%	1.7%	1.3%	14.0%	7.4%	0.3×	0.95×	9.68×	0.9×	0.0%	7	3.7	3	B+
HNSA.STHansa Biopharma AB (publ)	SEK 41.30	-5.22×	-31.35×	12.55×	-6.25×	-323.4%	62.4%	-234.3%	-240.3%	600.2%	-57.8%	-19.7%	-10.49×	-0.48×	-4.43×	1.94×	0.0%	2	-0.05	2	C
JAZZJazz Pharmaceuticals plc	$242.52	-29.11×	2.4×	2.43×	54.8×	84.2%	88.2%	5.3%	-8.3%	-8.2%	1.2%	11.1%	1.26×	15.34×	1.15×	1.86×	0.0%	8	2.36	4	A-
UCB.BRUCB S.A.	€297.80	29.1×	4.17×	5.86×	25.28×	35.1%	71.1%	15.1%	20.1%	14.3%	7.2%	4.2%	0.21×	-0×	9.11×	1.38×	0.6%	6	4.94	4	A-
Peer median	—	-5.22×	2.4×	5.86×	25.28×	35.1%	71.1%	5.3%	-8.3%	14.3%	1.2%	4.2%	0.21×	-0×	1.15×	1.86×	0.0%	6	2.36	4	—